On 22 February, Regulus Therapeutics Inc. (NASDAQ:RGLS) reported a net loss of $7.2 million and $55.7 million for the quarter and year ended December 31, 2015, respectively, compared to a net loss of $22.2 million and $56.7 million for the same periods in 2014. Basic and diluted net loss per share was $0.14 for the quarter ended December 31, 2015, compared to $0.47 for the same period in 2014. Basic and diluted net loss per share was $1.08 for the year ended December 31, 2015, compared to $1.29 for the same period in 2014.
Regulus Therapeutics Inc. (NASDAQ:RGLS) belongs to Healthcare sector. Its weekly performance is -19.55%. On last trading day company shares ended up at $6.38.
Glancy Prongay & Murray LLP (“GPM”) announces an expanded class period in the class action lawsuit filed on behalf of investors who purchased GoPro, Inc. (NASDAQ: GPRO) securities between November 26, 2014 and January 13, 2016, inclusive (the “Class Period”). Injured investors with losses of $1,000,000 or more are encouraged to contact Lesley Portnoy of GPM at 310-201-9150 prior to the March 14, 2016 lead plaintiff deadline to discuss their legal rights.
GoPro, Inc. (NASDAQ:GPRO) shares fell -3.49% in last trading session and ended the day at $11.34. GPRO Gross Margin is 41.60% and its return on assets is 3.30%. GoPro, Inc. (NASDAQ:GPRO) quarterly performance is -40.28%.
NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel immuno-oncology product candidates, including both cellular immunotherapy and checkpoint inhibitor platforms, will release its fourth quarter and year end 2015 financial results on Monday, February 29, 2016.
On 25 February, NewLink Genetics Corporation (NASDAQ:NLNK) shares fell -5.39% and was closed at $21.25. NLNK EPS growth in last 5 year was 54.90%. NewLink Genetics Corporation (NASDAQ:NLNK) year to date (YTD) performance is -41.60%.
Aetna (NYSE: AET) and Roxborough Memorial Hospital announced that they have reached agreement on a new three-year contract that took effect Feb. 1. The agreement returns Roxborough Memorial Hospital to Aetna’s network of contracted hospitals for the first time since 2012.
Aetna Inc. (NYSE:AET) ended the last trading day at $109.40. Company weekly volatility is calculated as 2.75% and price to cash ratio as 21.23. Aetna Inc. (NYSE:AET) showed a weekly performance of 4.81%.
Ultra Clean Holdings (NASDAQ: UCTT) reported Q4 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $103.4 million versus the consensus estimate of $102.1 million. GUIDANCE: Ultra Clean Holdings sees Q1 2016 EPS of $0.01-$0.04, versus the consensus of $0.01. Ultra Clean Holdings sees Q1 2016 revenue of $108-113 million, versus the consensus of $105.12 million.
Ultra Clean Holdings Inc. (NASDAQ:UCTT) shares moved up 1.92% in last trading session and ended the day at $5.30. UCTT Gross Margin is 15.70% and its return on assets is 2.60%. Ultra Clean Holdings Inc. (NASDAQ:UCTT) quarterly performance is 12.29%.